Delphine Hudry

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 16

Top Venues

Current oncology (Toronto, Ont.)

Cancers

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Current oncology reports

LABORATOIRE PRISM U 1192

This page only lists publications with an associated author ORCID identifier.

Affiliation History

LABORATOIRE PRISM U 1192 Feb 01 2018

France

PhD student

Publications

Manon Lefebvre, Mathilde Duchatelet, Houssein El Hajj, Antoine De Courrèges, Jennifer Wallet, Charlotte Bellier, Florence Le Tinier, Marie-Cécile Le Deley, Carlos Martinez Gomez, Éric Leblanc, Fabrice Narducci, Delphine Hudry
Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy? Current oncology (Toronto, Ont.) 30 (1) (2023)
Manel Montesinos, Pierre-Antoine Giroux, Delphine Hudry, Camille Pasquesoone, Fabrice Narducci, Carlos Martinez-Gomez
Complex abdominal wall reconstruction for an isolated parietal recurrence of ovarian cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Benjamin Serouart, Abel Cordoba, Carlos Martinez-Gomez, Emilie Bogart, Marie-Cécile Le Deley, Éric Leblanc, Delphine Hudry, Alexandre Escande, Florence Le Tinier, Camille Pasquesoone, Sophie Taieb, Houssein El Hajj, Fabrice Narducci
Results of a 20 Year Retrospective Analysis of Early-Stage Cervical Cancer: Should 3 cm Be Considered the New Ariadne's Thread in Early Cervical Cancer Treatment? Cancers 15 (5) (2023)
Manon Lefebvre, Mathilde Duchatelet, Houssein El Hajj, Antoine De Courrèges, Jennifer Wallet, Charlotte Bellier, Florence Le Tinier, Marie-Cécile Le Deley, Carlos Martinez Gomez, Éric Leblanc, Fabrice Narducci, Delphine Hudry
Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy? Current oncology (Toronto, Ont.) 30 (1) (2023)
Éric Leblanc, Fabrice Narducci, Gwenaël Ferron, Audrey Mailliez, Jean-Yves Charvolin, Houssein El Hajj, Frédéric Guyon, Virginie Fourchotte, Eric Lambaudie, Agathe Crouzet, Yves Fouche, Sébastien Gouy, Pierre Collinet, Frédéric Caquant, Christophe Pomel, François Golfier, Véronique Vaini-Cowen, Isabelle Fournier, Michel Salzet, Emmanuelle Tresch, Alicia Probst, Anne-Sophie Lemaire, Marie-Cécile Le Deley, Delphine Hudry
Prophylactic Radical Fimbriectomy with Delayed Oophorectomy in Women with a High Risk of Developing an Ovarian Carcinoma: Results of a Prospective National Pilot Study. Cancers 15 (4) (2023)
Éric Leblanc, Fabrice Narducci, Gwenaël Ferron, Audrey Mailliez, Jean-Yves Charvolin, Houssein El Hajj, Frédéric Guyon, Virginie Fourchotte, Eric Lambaudie, Agathe Crouzet, Yves Fouche, Sébastien Gouy, Pierre Collinet, Frédéric Caquant, Christophe Pomel, François Golfier, Véronique Vaini-Cowen, Isabelle Fournier, Michel Salzet, Emmanuelle Tresch, Alicia Probst, Anne-Sophie Lemaire, Marie-Cécile Le Deley, Delphine Hudry
Prophylactic Radical Fimbriectomy with Delayed Oophorectomy in Women with a High Risk of Developing an Ovarian Carcinoma: Results of a Prospective National Pilot Study. Cancers 15 (4) (2023)
Benjamin Serouart, Abel Cordoba, Carlos Martinez-Gomez, Emilie Bogart, Marie-Cécile Le Deley, Éric Leblanc, Delphine Hudry, Alexandre Escande, Florence Le Tinier, Camille Pasquesoone, Sophie Taieb, Houssein El Hajj, Fabrice Narducci
Results of a 20 Year Retrospective Analysis of Early-Stage Cervical Cancer: Should 3 cm Be Considered the New Ariadne's Thread in Early Cervical Cancer Treatment? Cancers 15 (5) (2023)
Manon Lefebvre, Mathilde Duchatelet, Houssein El Hajj, Antoine De Courrèges, Jennifer Wallet, Charlotte Bellier, Florence Le Tinier, Marie-Cécile Le Deley, Carlos Martinez Gomez, Éric Leblanc, Fabrice Narducci, Delphine Hudry
Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy? Current oncology (Toronto, Ont.) 30 (1) (2023)
Éric Leblanc, Fabrice Narducci, Gwenaël Ferron, Audrey Mailliez, Jean-Yves Charvolin, Houssein El Hajj, Frédéric Guyon, Virginie Fourchotte, Eric Lambaudie, Agathe Crouzet, Yves Fouche, Sébastien Gouy, Pierre Collinet, Frédéric Caquant, Christophe Pomel, François Golfier, Véronique Vaini-Cowen, Isabelle Fournier, Michel Salzet, Emmanuelle Tresch, Alicia Probst, Anne-Sophie Lemaire, Marie-Cécile Le Deley, Delphine Hudry
Prophylactic Radical Fimbriectomy with Delayed Oophorectomy in Women with a High Risk of Developing an Ovarian Carcinoma: Results of a Prospective National Pilot Study. Cancers 15 (4) (2023)
Manon Lefebvre, Mathilde Duchatelet, Houssein El Hajj, Antoine De Courrèges, Jennifer Wallet, Charlotte Bellier, Florence Le Tinier, Marie-Cécile Le Deley, Carlos Martinez Gomez, Éric Leblanc, Fabrice Narducci, Delphine Hudry
Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy? Current oncology (Toronto, Ont.) 30 (1) (2023)
Abel Cordoba, Houssein El Hajj, Carlos Martinez-Gomez, Delphine Hudry, Fabrice Narducci
Should the cut-off for concomitant radiochemotherapy and intracavitary 3D adaptive uterovaginal brachytherapy be 3 cm? International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Manon Lefebvre, Mathilde Duchatelet, Houssein El Hajj, Antoine De Courrèges, Jennifer Wallet, Charlotte Bellier, Florence Le Tinier, Marie-Cécile Le Deley, Carlos Martinez Gomez, Éric Leblanc, Fabrice Narducci, Delphine Hudry
Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy? Current oncology (Toronto, Ont.) 30 (1) (2023)
Manon Lefebvre, Mathilde Duchatelet, Houssein El Hajj, Antoine De Courrèges, Jennifer Wallet, Charlotte Bellier, Florence Le Tinier, Marie-Cécile Le Deley, Carlos Martinez Gomez, Éric Leblanc, Fabrice Narducci, Delphine Hudry
Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy? Current oncology (Toronto, Ont.) 30 (1) (2023)
Delphine Hudry, Solenn Le Guellec, Samuel Meignan, Stéphanie Bécourt, Camille Pasquesoone, Houssein El Hajj, Carlos Martínez-Gómez, Éric Leblanc, Fabrice Narducci, Sylvain Ladoire
Tumor-Infiltrating Lymphocytes (TILs) in Epithelial Ovarian Cancer: Heterogeneity, Prognostic Impact, and Relationship with Immune Checkpoints. Cancers 14 (21) (2022)
Delphine Hudry, Stéphanie Bécourt, Giovanni Scambia, Anna Fagotti
Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision-a Literature Review. Current oncology reports 24 (12) (2022)
Pierre Alain Reboux, Henri Azais, Charles Henry Canova, Sofiane Bendifallah, Ouldamer Lobna, Raimond Émilie, Delphine Hudry, Charles Coutant, Olivier Graesslin, Cyril Touboul, Pierre Collinet, Alexandre Bricou, Cyrille Huchon, Emile Daraï, Ballester Marcos, Jean Lévêque, Vincent Lavoue, Martin Koskas, Catherine Uzan, Geoffroy Canlorbe
Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group. Journal of gynecologic oncology 30 (4) (2019)

Delphine Hudry.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Delphine Hudry